Australian (ASX) Stock Market Forum

Coronavirus (COVID-19/SARS-CoV-2) outbreak discussion

Will the "Corona Virus" turn into a worldwide epidemic or fizzle out?

  • Yes

    Votes: 37 49.3%

  • No

    Votes: 9 12.0%

  • Bigger than SARS, but not worldwide epidemic (Black Death/bubonic plague)

    Votes: 25 33.3%

  • Undecided

    Votes: 4 5.3%
  • Total voters
    75
Jump to new
wayneL said:
No, bro. It's about facts. Nothing our Swedish friend has said can be disputed.

You rely on unwarranted disparagement and ad hominem and refuse to step up with any sort of objective argument.
Click to expand...
Ok I'll bite
Tell me about the facial recognition
 
Lrts try number 1 Mr Newman
Building quarantine camps......like the one they use in Darwin?
Where we all stayed building the gas plant,ask anyone was the best camp ever
Why not throw in using hotels as quarantine
Cherry picked a pile of rubbish and you share it.....the anti vaxx man who relies on his sister in laws advice because of a math degree
Build that bunker man
 
Interesting


Having SARS-CoV-2 once confers much greater immunity than a vaccine —​

but vaccination remains vital​



Israelis who had an infection were more protected against the Delta coronavirus variant than those who had​

an already highly effective COVID-19 vaccine​



The natural immune protection that develops after a SARS-CoV-2 infection offers considerably more of a shield against the Delta variant of the pandemic coronavirus than two doses of the Pfizer-BioNTech vaccine, according to a large Israeli study that some scientists wish came with a “Don’t try this at home” label. The newly released data show people who once had a SARS-CoV-2 infection were much less likely than never-infected, vaccinated people to get Delta, develop symptoms from it, or become hospitalized with serious COVID-19.​
​
The study demonstrates the power of the human immune system, but infectious disease experts emphasized that this vaccine and others for COVID-19 nonetheless remain highly protective against severe disease and death. And they caution that intentional infection among unvaccinated people would be extremely risky. “What we don’t want people to say is: ‘All right, I should go out and get infected, I should have an infection party,’” says Michel Nussenzweig, an immunologist at Rockefeller University who researches the immune response to SARS-CoV-2 and was not involved in the study. “Because somebody could die.”​
​
The researchers also found that people who had SARS-CoV-2 previously and received one dose of the Pfizer-BioNTech messenger RNA (mRNA) vaccine were more highly protected against reinfection than those who once had the virus and were still unvaccinated. The new work could inform discussion of whether previously infected people need to receive both doses of the Pfizer-BioNTech vaccine or the similar mRNA vaccine from Moderna. Vaccine mandates don’t necessarily exempt those who had a SARS-CoV-2 infection already and the current U.S. recommendation is that they be fully vaccinated, which means two mRNA doses or one of the Johnson & Johnson adenovirus-based vaccine. Yet one mRNA dose might be enough, some scientists argue. And other countries including Germany, France, Italy, and Israel administer just one vaccine dose to previously infected people.​
​
The study, conducted in one of the most highly COVID-19–vaccinated countries in the world, examined medical records of tens of thousands of Israelis, charting their infections, symptoms, and hospitalizations between 1 June and 14 August, when the Delta variant predominated in Israel. It’s the largest real-world observational study so far to compare natural and vaccine-induced immunity to SARS-CoV-2, according to its leaders.​
​
The research impresses Nussenzweig and other scientists who have reviewed a preprint of the results, posted yesterday on medRxiv. “It’s a textbook example of how natural immunity is really better than vaccination,” says Charlotte Thålin, a physician and immunology researcher at Danderyd Hospital and the Karolinska Institute who studies the immune responses to SARS-CoV-2. “To my knowledge, it’s the first time [this] has really been shown in the context of COVID-19.”​
​
Still, Thålin and other researchers stress that deliberate infection among unvaccinated people would put them at significant risk of severe disease and death, or the lingering, significant symptoms of what has been dubbed Long Covid. The study shows the benefits of natural immunity, but “doesn’t take into account what this virus does to the body to get to that point,” says Marion Pepper, an immunologist at the University of Washington, Seattle. COVID-19 has already killed more than 4 million people worldwide and there are concerns that Delta and other SARS-CoV-2 variants are deadlier than the original virus.​
​
The new analysis relies on the database of Maccabi Healthcare Services, which enrolls about 2.5 million Israelis. The study, led by Tal Patalon and Sivan Gazit at KSM, the system’s research and innovation arm, found in two analyses that never-infected people who were vaccinated in January and February were, in June, July, and the first half of August, six to 13 times more likely to get infected than unvaccinated people who were previously infected with the coronavirus. In one analysis, comparing more than 32,000 people in the health system, the risk of developing symptomatic COVID-19 was 27 times higher among the vaccinated, and the risk of hospitalization eight times higher.​
​
“The differences are huge,” says Thålin, although she cautions that the numbers for infections and other events analyzed for the comparisons were “small.” For instance, the higher hospitalization rate in the 32,000-person analysis was based on just eight hospitalizations in a vaccinated group and one in a previously infected group. And the 13-fold increased risk of infection in the same analysis was based on just 238 infections in the vaccinated population, less than 1.5% of the more than 16,000 people, versus 19 reinfections among a similar number of people who once had SARS-CoV-2.​
​
No one in the study who got a new SARS-CoV-2 infection died—which prevented a comparison of death rates but is a clear sign that vaccines still offer a formidable shield against serious disease, even if not as good as natural immunity. Moreover, natural immunity is far from perfect. Although reinfections with SARS-CoV-2 are rare, and often asymptomatic or mild, they can be severe.​
​
In another analysis, the researchers compared more than 14,000 people who had a confirmed SARS-CoV-2 infection and were still unvaccinated with an equivalent number of previously infected people who received one dose of the Pfizer-BioNTech vaccine. The team found that the unvaccinated group was twice as likely to be reinfected as the singly vaccinated.​
​
“We continue to underestimate the importance of natural infection immunity … especially when [infection] is recent,” says Eric Topol, a physician-scientist at Scripps Research. “And when you bolster that with one dose of vaccine, you take it to levels you can’t possibly match with any vaccine in the world right now.”​
​
Nussenzweig says the results in previously infected, vaccinated people confirm laboratory findings from a series of papers in Nature and Immunity by his group, his Rockefeller University colleague Paul Bieniasz and others—and from a preprint posted this month by Bieniasz and his team. They show, Nussenzweig says, that the immune systems of people who develop natural immunity to SARS-CoV-2 and then get vaccinated produce exceptionally broad and potent antibodies against the coronavirus. The preprint, for example, reported that people who were previously infected and then vaccinated with an mRNA vaccine had antibodies in their blood that neutralized the infectivity of another virus, harmless to humans, that was engineered to express a version of the coronavirus spike protein that contains 20 concerning mutations. Sera from vaccinated and naturally infected people could not do so.​


More on link below...


https://www.science.org/content/art...er-immunity-vaccine-vaccination-remains-vital



New preprint data suggests prior COVID infection generates fantastic immunity.

What it means for vaccines, mandates, and more.





.​
 
Looks like vaccine hesitancy, has gone out the window in Victoria as well:

Victoria just a fortnight from extra freedoms due to high vaccination numbers​

By Craig Butt and Ashleigh McMillan​

Victoria is just a fortnight from additional freedoms, with new data showing the state is only 14 days away from reaching 70 per cent first COVID-19 doses for the eligible population.
The vaccination target could now be reached on September 18, if Victorians continue to get jabbed at the pace with which the state’s vaccine rollout has progressed over the past seven days.

Premier Daniel Andrews announced earlier this week that some restrictions will ease in Victoria once 70 per cent of the eligible population over 16 years receive their first COVID-19 vaccine dose.
Lockdown rules including the 5km travel limit, outdoor exercise and personal training, and private real estate inspections are set to be loosened.
Health authorities said earlier this week they expected the vaccination target could be achieved by September 23.
There were 33,511 vaccine doses administered in state-run hubs and clinics on Thursday.
 
DB008 said:
Interesting


Having SARS-CoV-2 once confers much greater immunity than a vaccine —​

but vaccination remains vital​



Israelis who had an infection were more protected against the Delta coronavirus variant than those who had​

an already highly effective COVID-19 vaccine​



The natural immune protection that develops after a SARS-CoV-2 infection offers considerably more of a shield against the Delta variant of the pandemic coronavirus than two doses of the Pfizer-BioNTech vaccine, according to a large Israeli study that some scientists wish came with a “Don’t try this at home” label. The newly released data show people who once had a SARS-CoV-2 infection were much less likely than never-infected, vaccinated people to get Delta, develop symptoms from it, or become hospitalized with serious COVID-19.​
​
The study demonstrates the power of the human immune system, but infectious disease experts emphasized that this vaccine and others for COVID-19 nonetheless remain highly protective against severe disease and death. And they caution that intentional infection among unvaccinated people would be extremely risky. “What we don’t want people to say is: ‘All right, I should go out and get infected, I should have an infection party,’” says Michel Nussenzweig, an immunologist at Rockefeller University who researches the immune response to SARS-CoV-2 and was not involved in the study. “Because somebody could die.”​
​
The researchers also found that people who had SARS-CoV-2 previously and received one dose of the Pfizer-BioNTech messenger RNA (mRNA) vaccine were more highly protected against reinfection than those who once had the virus and were still unvaccinated. The new work could inform discussion of whether previously infected people need to receive both doses of the Pfizer-BioNTech vaccine or the similar mRNA vaccine from Moderna. Vaccine mandates don’t necessarily exempt those who had a SARS-CoV-2 infection already and the current U.S. recommendation is that they be fully vaccinated, which means two mRNA doses or one of the Johnson & Johnson adenovirus-based vaccine. Yet one mRNA dose might be enough, some scientists argue. And other countries including Germany, France, Italy, and Israel administer just one vaccine dose to previously infected people.​
​
The study, conducted in one of the most highly COVID-19–vaccinated countries in the world, examined medical records of tens of thousands of Israelis, charting their infections, symptoms, and hospitalizations between 1 June and 14 August, when the Delta variant predominated in Israel. It’s the largest real-world observational study so far to compare natural and vaccine-induced immunity to SARS-CoV-2, according to its leaders.​
​
The research impresses Nussenzweig and other scientists who have reviewed a preprint of the results, posted yesterday on medRxiv. “It’s a textbook example of how natural immunity is really better than vaccination,” says Charlotte Thålin, a physician and immunology researcher at Danderyd Hospital and the Karolinska Institute who studies the immune responses to SARS-CoV-2. “To my knowledge, it’s the first time [this] has really been shown in the context of COVID-19.”​
​
Still, Thålin and other researchers stress that deliberate infection among unvaccinated people would put them at significant risk of severe disease and death, or the lingering, significant symptoms of what has been dubbed Long Covid. The study shows the benefits of natural immunity, but “doesn’t take into account what this virus does to the body to get to that point,” says Marion Pepper, an immunologist at the University of Washington, Seattle. COVID-19 has already killed more than 4 million people worldwide and there are concerns that Delta and other SARS-CoV-2 variants are deadlier than the original virus.​
​
The new analysis relies on the database of Maccabi Healthcare Services, which enrolls about 2.5 million Israelis. The study, led by Tal Patalon and Sivan Gazit at KSM, the system’s research and innovation arm, found in two analyses that never-infected people who were vaccinated in January and February were, in June, July, and the first half of August, six to 13 times more likely to get infected than unvaccinated people who were previously infected with the coronavirus. In one analysis, comparing more than 32,000 people in the health system, the risk of developing symptomatic COVID-19 was 27 times higher among the vaccinated, and the risk of hospitalization eight times higher.​
​
“The differences are huge,” says Thålin, although she cautions that the numbers for infections and other events analyzed for the comparisons were “small.” For instance, the higher hospitalization rate in the 32,000-person analysis was based on just eight hospitalizations in a vaccinated group and one in a previously infected group. And the 13-fold increased risk of infection in the same analysis was based on just 238 infections in the vaccinated population, less than 1.5% of the more than 16,000 people, versus 19 reinfections among a similar number of people who once had SARS-CoV-2.​
​
No one in the study who got a new SARS-CoV-2 infection died—which prevented a comparison of death rates but is a clear sign that vaccines still offer a formidable shield against serious disease, even if not as good as natural immunity. Moreover, natural immunity is far from perfect. Although reinfections with SARS-CoV-2 are rare, and often asymptomatic or mild, they can be severe.​
​
In another analysis, the researchers compared more than 14,000 people who had a confirmed SARS-CoV-2 infection and were still unvaccinated with an equivalent number of previously infected people who received one dose of the Pfizer-BioNTech vaccine. The team found that the unvaccinated group was twice as likely to be reinfected as the singly vaccinated.​
​
“We continue to underestimate the importance of natural infection immunity … especially when [infection] is recent,” says Eric Topol, a physician-scientist at Scripps Research. “And when you bolster that with one dose of vaccine, you take it to levels you can’t possibly match with any vaccine in the world right now.”​
​
Nussenzweig says the results in previously infected, vaccinated people confirm laboratory findings from a series of papers in Nature and Immunity by his group, his Rockefeller University colleague Paul Bieniasz and others—and from a preprint posted this month by Bieniasz and his team. They show, Nussenzweig says, that the immune systems of people who develop natural immunity to SARS-CoV-2 and then get vaccinated produce exceptionally broad and potent antibodies against the coronavirus. The preprint, for example, reported that people who were previously infected and then vaccinated with an mRNA vaccine had antibodies in their blood that neutralized the infectivity of another virus, harmless to humans, that was engineered to express a version of the coronavirus spike protein that contains 20 concerning mutations. Sera from vaccinated and naturally infected people could not do so.​


More on link below...


https://www.science.org/content/art...er-immunity-vaccine-vaccination-remains-vital



New preprint data suggests prior COVID infection generates fantastic immunity.

What it means for vaccines, mandates, and more.





.​
Click to expand...



Not surprised DB just the problem with natural selection, long COVID etc and with new variants that's maybe where we all end up.
 
What we do have to remember, is to take Australia's situation in an holistic way and compare the way it has panned out here compared to similar countries.
THIS IS DEATHS PER 1,000,000 people.
So it is not just total deaths, but deaths as represented by the population, of the country.
Screenshot 2021-09-03 193421.png
 
sptrawler said:
What we do have to remember, is to take Australia's situation in an holistic way and compare the way it has panned out here compared to similar countries.
THIS IS DEATHS PER 1,000,000 people.
So it is not just total deaths, but deaths as represented by the population, of the country.
View attachment 129834
Click to expand...
www.france24.com

Japan PM Suga to resign following criticism of his Covid-19 response

Japan's Prime Minister Yoshihide Suga said Friday he will not run for re-election as party leader this month, effectively ending his tenure after just one year, his party's secretary general said.
www.france24.com www.france24.com
holistic response
 
Humid said:
www.france24.com

Japan PM Suga to resign following criticism of his Covid-19 response

Japan's Prime Minister Yoshihide Suga said Friday he will not run for re-election as party leader this month, effectively ending his tenure after just one year, his party's secretary general said.
www.france24.com www.france24.com
holistic response
Click to expand...
Well if you want to start taking Japan as a lead, all the guys at Swanbourne, would be jumping on a bayonet.

Have you ever looked up Japanese politics? I know you don't get much time off, but just check up a little on your assumptions. You do know what assumptions are don't you?
www.theguardian.com

Japanese politicians brawl in parliament over bill to allow troops to fight abroad

MPs push and shove each other during a heated debate as 13,000 rally outside Tokyo’s parliament against proposed change to law
www.theguardian.com www.theguardian.com

qz.com

Photos: Japan’s lawmakers have a fistfight over pacifism

Violence in pursuit of peace.
qz.com qz.com

www.independent.co.uk

Japanese politicians brawl in parliament....in debate about pacifism

MPs fought over proposed legislation to allow Japanese troops to fight overseas for the first time in 70 years
www.independent.co.uk www.independent.co.uk
 
sptrawler said:
Well if you want to start taking Japan as a lead, all the guys at Swanbourne, would be jumping on a bayonet.

Have you ever looked up Japanese politics? I know you don't get much time off, but just check up a little on your assumptions. You do know what assumptions are don't you?
www.theguardian.com

Japanese politicians brawl in parliament over bill to allow troops to fight abroad

MPs push and shove each other during a heated debate as 13,000 rally outside Tokyo’s parliament against proposed change to law
www.theguardian.com www.theguardian.com

qz.com

Photos: Japan’s lawmakers have a fistfight over pacifism

Violence in pursuit of peace.
qz.com qz.com

www.independent.co.uk

Japanese politicians brawl in parliament....in debate about pacifism

MPs fought over proposed legislation to allow Japanese troops to fight overseas for the first time in 70 years
www.independent.co.uk www.independent.co.uk
Click to expand...
I assume they still build cars
 
IFocus said:
I don't read twitter but had this recommended

Click to expand...
Like we have said endlessly on the forum, the virus is here to stay, you can catch it with the vaccine or without the vaccine.
All the vaccine does, is reduce the effects, it's your choice.
Simple really.

This locking down to stop the virus, isn't a long term option, so people just have to make a choice.

The real problem is those who are hospitalised, become politicised, then the media have a field day.
How could you let this happen?
Why don't these people on ventilators matter?
A Government that didn't care and opened up too early.

Chook fodder, for the plebs.
 
IFocus said:
Not surprised DB just the problem with natural selection, long COVID etc and with new variants that's maybe where we all end up.
Click to expand...

100%. Covid-19 variants will probably turn into a yearly flu jab (maybe).

The cliff notes are - just get the jab.

My 2nd Pfizer jab was back at the end of July. No issues at all. If a booster jab becomes a thing (prefer Moderna or Johnson & Johnson), l'd get it right now. I think the biggest issue in Australia is the lack of supply. The Federal Government should also have the capability to make mRNA vaccine, we as a nation are exposed if we don't have that capability (compare the Chinese vaccine (Sinovac) effectiveness (65.9%, 90.3% for hospitalisation) to Pfizer/Moderna (90%)).


Sinovac - https://www.nejm.org/doi/full/10.1056/NEJMoa2107715







.​
 
Top